Skip to main content

Y-mAbs Therapeutics, Inc.

YMABDelisted Sep 16, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001722964

Y-mAbs Therapeutics, Inc. was delisted on Sep 16, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 97 institutions reported holding it in 13F filings for Q2 2025, worth $125.9M in total; no superinvestor held it.

13F holders, Q3 2021

Institutional positions in Y-mAbs Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
97
−3 vs. Q2 2021
Shares held
26.2M
+102.8K (+0.4%) vs. Q2 2021
Total value
$749.0M
−$137.9M (−15.5%) vs. Q2 2021
New holders
10
41 more added
Sold out
13
29 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting YMAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 97 institutions
Q1 2021: 117 institutionsQ2 2021: 100 institutionsQ3 2021: 97 institutionsQ4 2021: 97 institutionsQ1 2022: 88 institutionsQ2 2022: 91 institutionsQ3 2022: 100 institutionsQ4 2022: 91 institutionsQ1 2023: 86 institutionsQ2 2023: 95 institutionsQ3 2023: 99 institutionsQ4 2023: 94 institutionsQ1 2024: 96 institutionsQ2 2024: 96 institutionsQ3 2024: 105 institutionsQ4 2024: 113 institutionsQ1 2025: 103 institutionsQ2 2025: 97 institutionsQ3 2025: 2 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2021: $749.0M
Q1 2021: $804.8MQ2 2021: $886.9MQ3 2021: $749.0MQ4 2021: $417.1MQ1 2022: $300.6MQ2 2022: $374.7MQ3 2022: $339.7MQ4 2022: $94.2MQ1 2023: $95.4MQ2 2023: $132.4MQ3 2023: $107.3MQ4 2023: $138.0MQ1 2024: $374.0MQ2 2024: $294.2MQ3 2024: $338.5MQ4 2024: $225.5MQ1 2025: $127.6MQ2 2025: $125.9MQ3 2025: $78.3KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding YMAB and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20252$78.3K
Q2 202597$125.9M
Q1 2025103$127.6M
Q4 2024113$225.5M
Q3 2024105$338.5M
Q2 202496$294.2M
Q1 202496$374.0M
Q4 202394$138.0M
Q3 202399$107.3M
Q2 202395$132.4M
Q1 202386$95.4M
Q4 202291$94.2M
Q3 2022100$339.7M
Q2 202291$374.7M
Q1 202288$300.6M
Q4 202197$417.1M
Q3 202197$749.0M
Q2 2021100$886.9M
Q1 2021117$804.8M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Y-mAbs Therapeutics, Inc.; share changes are against Q2 2021.

Institutions holding YMAB in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
D. E. Shaw & Co., Inc.0$00.00%−39,083−100.0%Sold out
Hillsdale Investment Management Inc.0$00.00%−26,699−100.0%Sold out
Squarepoint Ops LLC0$00.00%−18,554−100.0%Sold out
Marshall Wace, LLP0$00.00%−12,310−100.0%Sold out
Trexquant Investment LP0$00.00%−8,690−100.0%Sold out
Marshall Wace North America L.P.0$00.00%−8,204−100.0%Sold out
Amalgamated Bank0$00.00%−6,599−100.0%Sold out
Credit Agricole S A0$00.00%−3,500−100.0%Sold out
Signaturefd, LLC0$00.00%−29−100.0%Sold out
Red Door Wealth Management, LLC0$00.00%−40−100.0%Sold out